date,title,source
Oct-18-18,Today's Research Reports on Trending Tickers: Immunomedics and FibroGen,ACCESSWIRE
Oct-25-18,FibroGen Presents Results from Two Phase 3 Studies of Roxadustat for the Treatment of Anemia Associated with Chronic Kidney Disease Conducted in China at American Society of Nephrology Kidney Week 2018 Annual Meeting,GlobeNewswire
Oct-30-18,ASN Kidney Week 2018: Data Presented from Two Japanese Phase 3 Studies on Roxadustat in the Treatment of Anemia Associated with Chronic Kidney Disease in Patients on Dialysis,GlobeNewswire
Nov-05-18,What Kind Of Shareholder Appears On The FibroGen Incs (NASDAQ:FGEN) Shareholder Register?,Simply Wall St.
